Literature DB >> 24187099

Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.

Sheila T Angeles-Han1, Christina F Pelajo, Larry B Vogler, Kelly Rouster-Stevens, Christine Kennedy, Lori Ponder, Courtney McCracken, Jorge Lopez-Benitez, Carolyn Drews-Botsch, Sampath Prahalad.   

Abstract

OBJECTIVE: To characterize the epidemiology and clinical course of children with juvenile idiopathic arthritis-associated uveitis (JIA-U) in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry and explore differences between African American (AA) and non-Hispanic white (NHW) children.
METHODS: There were 4983 children with JIA enrolled in the CARRA Registry. Of those, 3967 NHW and AA children were included in this study. Demographic and disease-related data were collected from diagnosis to enrollment. Children with JIA were compared to those with JIA-U. Children with JIA-U were also compared by race.
RESULTS: There were 459/3967 children (11.6%) with JIA-U in our cohort with a mean age (SD) of 11.4 years (± 4.5) at enrollment. Compared to children with JIA, they were younger at arthritis onset, more likely to be female, had < 5 joints involved, had oligoarticular JIA, and were antinuclear antibody (ANA)-positive, rheumatoid factor (RF)-negative, and anticitrullinated protein antibody-negative. Predictors of uveitis development included female sex, early age of arthritis onset, and oligoarticular JIA. Polyarticular RF-positive JIA subtype was protective. Nearly 3% of children with JIA-U were AA. However, of the 220 AA children with JIA, 6% had uveitis; in contrast, 12% of the 3721 NHW children with JIA had uveitis.
CONCLUSION: In the CARRA registry, the prevalence of JIA-U in AA and NHW children is 11.6%. We confirmed known uveitis risk markers (ANA positivity, younger age at arthritis onset, and oligoarticular JIA). We describe a decreased likelihood of uveitis in AA children and recommend further exploration of race as a risk factor in a larger population of AA children.

Entities:  

Keywords:  JUVENILE IDIOPATHIC ARTHRITIS; OUTCOMES; RISK MARKERS; UVEITIS

Mesh:

Year:  2013        PMID: 24187099      PMCID: PMC4117408          DOI: 10.3899/jrheum.130302

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  48 in total

Review 1.  Uveitis in children.

Authors:  Manfred Zierhut; Hartmut Michels; Nicole Stübiger; Dorothea Besch; Christoph Deuter; Arnd Heiligenhaus
Journal:  Int Ophthalmol Clin       Date:  2005

Review 2.  Juvenile idiopathic arthritis.

Authors:  Angelo Ravelli; Alberto Martini
Journal:  Lancet       Date:  2007-03-03       Impact factor: 79.321

3.  Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study.

Authors:  K Kotaniemi; H Kautiainen; A Karma; K Aho
Journal:  Ophthalmology       Date:  2001-11       Impact factor: 12.079

4.  Acute anterior uveitis and HL-A 27.

Authors:  D A Brewerton; M Caffrey; A Nicholls; D Walters; D C James
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

5.  Polyarthritis in Western Nigeria. II. Still's disease.

Authors:  B M Greenwood
Journal:  Ann Rheum Dis       Date:  1969-11       Impact factor: 19.103

6.  Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines.

Authors:  A Heiligenhaus; M Niewerth; G Ganser; C Heinz; K Minden
Journal:  Rheumatology (Oxford)       Date:  2007-04-02       Impact factor: 7.580

7.  Prognosis of juvenile rheumatoid arthritis-associated uveitis.

Authors:  M P Paroli; S Speranza; M Marino; M P Pirraglia; P Pivetti-Pezzi
Journal:  Eur J Ophthalmol       Date:  2003 Aug-Sep       Impact factor: 2.597

8.  Course, complications, and outcome of juvenile arthritis-related uveitis.

Authors:  Kourosh Sabri; Rotraud K Saurenmann; Earl D Silverman; Alex V Levin
Journal:  J AAPOS       Date:  2008-09-12       Impact factor: 1.220

9.  Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.

Authors:  R K Saurenmann; A V Levin; J B Rose; S Parker; T Rabinovitch; P N Tyrrell; B M Feldman; R M Laxer; R Schneider; E D Silverman
Journal:  Rheumatology (Oxford)       Date:  2006-02-03       Impact factor: 7.580

Review 10.  Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis.

Authors:  C Stephen Foster
Journal:  Curr Opin Ophthalmol       Date:  2003-12       Impact factor: 3.761

View more
  42 in total

Review 1.  The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.

Authors:  Melissa A Lerman; C Egla Rabinovich
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

2.  Juvenile idiopathic arthritis in the biologic era: predictors of the disease progression and need for early introduction of biologic treatment.

Authors:  Panayiota Nalbanti; Florentia Kanakoudi-Tsakalidou; Maria Trachana; Polyxeni Pratsidou-Gertsi; Evangelia Farmaki; Panagiotis Bamidis; Fotios Papachristou
Journal:  Rheumatol Int       Date:  2018-05-29       Impact factor: 2.631

Review 3.  Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?

Authors:  Heinrike Schmeling; Gerd Horneff; Susanne M Benseler; Marvin J Fritzler
Journal:  Nat Rev Rheumatol       Date:  2014-08-12       Impact factor: 20.543

Review 4.  Uveitis associated with juvenile idiopathic arthritis.

Authors:  Ethan S Sen; Andrew D Dick; Athimalaipet V Ramanan
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

Review 5.  Uveitis in children.

Authors:  Sheila T Angeles-Han; Consuelo Egla Rabinovich
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

6.  Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children.

Authors:  Lauren Fitzpatrick; K Alaine Broadaway; Lori Ponder; Sheila T Angeles-Han; Kirsten Jenkins; Kelly Rouster-Stevens; Christina F Pelajo; Karen Conneely; Michael P Epstein; Jorge Lopez-Benitez; Larry B Vogler; Sampath Prahalad
Journal:  J Rheumatol       Date:  2016-02-15       Impact factor: 4.666

7.  Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for Juvenile Idiopathic Arthritis-Associated and Idiopathic Chronic Anterior Uveitis.

Authors:  Sheila T Angeles-Han; Mindy S Lo; Lauren A Henderson; Melissa A Lerman; Leslie Abramson; Ashley M Cooper; Miriam F Parsa; Lawrence S Zemel; Tova Ronis; Timothy Beukelman; Erika Cox; H Nida Sen; Gary N Holland; Hermine I Brunner; Andrew Lasky; C Egla Rabinovich
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-04       Impact factor: 4.794

8.  Timing of infliximab and adalimumab initiation despite methotrexate in children with chronic non-infectious anterior uveitis.

Authors:  Courtney McCracken; Steven Yeh; Kirsten Jenkins; Curtis Travers; Daneka Stryker; Steven Tommasello; Kelly A Rouster-Stevens; Scott R Lambert; Sampath Prahalad; Carolyn Drews-Botsch; Sheila T Angeles-Han
Journal:  Eye (Lond)       Date:  2018-11-28       Impact factor: 3.775

9.  The Association of Race With Childhood Uveitis.

Authors:  Sheila T Angeles-Han; Courtney McCracken; Steven Yeh; Kirsten Jenkins; Daneka Stryker; Curtis Travers; Kelly Rouster-Stevens; Larry B Vogler; Scott R Lambert; Carolyn Drews-Botsch; Sampath Prahalad
Journal:  Am J Ophthalmol       Date:  2015-08-06       Impact factor: 5.258

Review 10.  Ocular Involvement in Juvenile Idiopathic Arthritis: Classification and Treatment.

Authors:  Ivan Foeldvari
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.